Abstract:Purpose: The absence of a complete endothelial cell layer is a well-recognized reason leading to small-diameter tissue-engineered vascular graft failure. Here we reported a multifunctional system consisting of chitosan (CS), Arg-Glu-Asp-Val (REDV) peptide, heparin, and vascular endothelial growth factor (VEGF) to achieve sustained anti-thrombosis and rapid endothelialization for decellularized and photo-oxidized bovine internal mammary arteries (DP-BIMA). Methods: CS-REDV copolymers were synthesized via a transglutaminase (TGase) catalyzed reaction. CS -REDV -Hep nanoparticles were formed by electrostatic self-assembly and loaded on the DP-BIMA. The quantification of released heparin and vascular endothelial growth factor was detected. Hemolysis rate, platelets adhesion, endothelial cell (EC) adhesion and proliferation, and MTT assay were performed in vitro . The grafts were then tested in a rabbit abdominal aorta interposition model for 3 months. The patency rates were calculated and the ECs regeneration was investigated by immunofluorescence staining of CD31, CD144, and eNOS antibodies. Results: The nanoparticle-VEGF system (particle size: 61.8 ± 18.3 nm, zeta-potential: +13.2 mV, PDI: .108) showed a sustained and controlled release of heparin and VEGF for as long as 1 month and exhibited good biocompatibility, a lower affinity for platelets, and a higher affinity for ECs in vitro . The nanoparticle-VEGF immobilized BIMA achieved 100% and 83.3% patency in a rabbit abdominal interposition model during 1 and 3 months, respectively, without any thrombogenicity and showed CD31, CD144, eNOS positive cell adhesion as early as 1 day. After 3 months, CD31, CD144, and eNOS positive cells covered almost the whole luminal surface of the grafts. Conclusion: The results demonstrated that the multifunctional nanoparticle-VEGF system can enhance the anti-thrombosis property and promote rapid endothelialization of small-diameter tissue-engineered vascular grafts. Utilizing nanoparticles to combine different kinds of biomolecules is an appropriate technology to improve the long-term patency of small-diameter tissue-engineered vascular grafts.

Biomimetic Antithrombotic Tissue‐Engineered Vascular Grafts for Converting Cholesterol and Free Radicals into Nitric Oxide

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Construction of Tissue-Engineered Vascular Grafts with Enhanced Patency by Integrating Heparin, Cell-Adhesive Peptide, and Carbon Monoxide Nanogenerators into Acellular Blood Vessels

Endothelium-Mimetic Surface Modification Improves Antithrombogenicity and Enhances Patency of Vascular Grafts in Rats and Pigs

Biomimetic Niche of Vascular Intima with Biophysical Orientation and Biochemical Stimulation for Rapid Endothelialization and Long-Term Patency

Construction of Tissue-Engineered Vascular Grafts with High Patency by Mimicking Immune Stealth and Blocking TGF-β Mediated Endothelial-to-mesenchymal Transition

Bilayer Vascular Grafts with On-Demand NO and H2S Release Capabilities.

Decellularization, cross-linking and heparin immobilization of porcine carotid arteries for tissue engineering vascular grafts

Regulation of Macrophage Polarization and Promotion of Endothelialization by NO Generating and PEG-YIGSR Modified Vascular Graft.

Hydrogen Sulfide Releasing and Carboxybetaine Modified Vascular Graft with Enhanced Anticoagulant, Anticalcification, and Pro-Endothelialization Properties

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

Development And In Vivo Evaluation Of Small-Diameter Vascular Grafts Engineered By Outgrowth Endothelial Cells And Electrospun Chitosan/Poly(Epsilon-Caprolactone) Nanofibrous Scaffolds

A Small-Diameter Vascular Graft Promotes Rapid and Benign Remodeling of the Neointima Through Dual Release of Nitric Oxide and Hydrogen Sulfide

Carnosine-Copper Chelator- Modified Small-Diameter Vascular Grafts for the Promotion of Anticoagulation and Endothelial Regeneration

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H2S for Anti-Inflammation and Anticalcification

Tissue Engineering of Small-Diameter Vascular Grafts by Endothelial Progenitor Cells Seeding Heparin-Coated Decellularized Scaffolds.

Amelioration of Blood Compatibility and Endothelialization of Polycaprolactone Substrates by Surface-Initiated Atom Transfer Radical Polymerization

A chitosan modified asymmetric small-diameter vascular graft with anti-thrombotic and anti-bacterial functions for vascular tissue engineering.

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H<sub>2</sub>S for Anti-Inflammation and Anticalcification

Challenges and Strategies for Endothelializing Decellularized Small‐Diameter Tissue‐Engineered Vessel Grafts

Nitric Oxide Generation and Endothelial Progenitor Cells Recruitment for Improving Hemocompatibility and Accelerating Endothelialization of Tissue Engineering Heart Valve